Ethical and practical issues in conducting clinical trials in psoriasis and psoriatic arthritis

Annals of the Rheumatic Diseases

Volumn 64, Issue SUPPL. 2, 2005, Pages

  Kavanaugh, A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; ETHICS; INFLAMMATORY DISEASE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; SYSTEMIC DISEASE;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

ARTHRITIS, PSORIATIC; CLINICAL TRIALS; CONFLICT OF INTEREST; ETHICS, CLINICAL; HUMANS; INFORMED CONSENT; PSORIASIS; RESEARCH DESIGN;

EID: 14244261568     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.030817     Document Type: Conference Paper

References (14)

1. Beauchamp TL, Childness JF. Principles of biomedical ethics, 5th edn. New York: Oxford University Press 1988:1-546.
2. Montaner JS, O'Shaughnessy MV, Schechter MT. Industry-sponsored clinical research: a double-edged sword. Lancet 2001;358:1893-5.
3. Bodenheimer T. Uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med 2000;342:1539-44.
4. Kahn JP, Mastroianni AC. Moving from compliance to conscience; why we can and should improve the ethics of clinical research. Arch Intern Med 2001;161:925-8.
5. Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, et al. The uncertainty principle and industry-sponsored research. Lancet 2000;356:635-8.
6. Montori VM, Smieja M, Guyatt GH. Publication bias: a brief review for clinicians. Mayo Clin Proc 2000;75:1284-8.
7. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994;331:394-8.
8. Kleijnen J, de Craen AJ, van Everdingen J, Krol L. Placebo effect in double-blind clinical trials: a review of interactions with medications. Lancet 1994;344:1347-9.
9. Stein CM, Pincus T. Placebo-controlled trials in rheumatoid arthritis: ethical issues. Lancet 1999;353:400-3.
10. Hill AB. Medical ethics and controlled trials. BMJ 1963;i:1043-9.
11. Lewis JA, Jonsson B, Kreutz G, Sampaio C, van Zwieten-Boot B. Placebo controlled trials and the Declaration of Helsinki. Lancet 2002;359:1337-40.
12. The World Medial Association. www.wma.net/e/ (accessed 24 Sept 2004).
13. Shopiro H, Meslin E. Ethical issues in the design and conduct of clinical trials in developing countries. N Engl J Med 2001;345:139-42.
14. Forster HP, Emanuel E, Grady C. The 2000 revision of the Declaration of Helsinki: a step forward or more confusion? Lancet 2001;358:1449-53.